Symbols
Symbols
Aime
Products
News
Market
Watchlist
Brokers
News
/
Stock
/
NEO
NEO
Content Types
Newswire
Articles
Latest News Updates
15:49
NEO
--%
Neogenomics Stock Price Plummets with MACD and KDJ Death Crosses.
10:16
NEO
--%
Neogenomics's 15min chart shows KDJ Golden Cross, KDJ Death Cross indicator.
Monday Nov 10, 2025
17:44
NEO
--%
NeoGenomics' RaDaR Assay Data and Technology Platform Advancements: A Bull Case
Thursday Nov 06, 2025
15:02
NEO
--%
Neogenomics's 15min chart sees KDJ Death Cross, Bearish Marubozu signal.
Tuesday Nov 04, 2025
15:48
NEO
--%
Neogenomics' 15-minute chart shows MACD Death Cross, Bollinger Bands narrowing, KDJ Death Cross.
15:17
NEO
--%
Neogenomics's 15min chart shows KDJ Golden Cross, Bullish Marubozu.
03:05
NEO
--%
NeoGenomics: Avoiding the Risks in Q3 Earnings
Monday Nov 03, 2025
10:36
NEO
--%
Neogenomics's 15min chart shows Bollinger Bands expanding downward, bearish Marubozu.
Friday Oct 31, 2025
14:48
NEO
--%
Neogenomics' 15-min chart triggers Bollinger Bands expansion upward, bullish marubozu formation.
13:17
NEO
--%
Neogenomics' 15-min chart triggers Bollinger Bands Narrowing, KDJ Death Cross alert.
Thursday Oct 30, 2025
13:52
NEO
--%
NeoGenomics to Showcase RaDaR ST Bridging Study and NextGen MRD Research at ISLB 2025.
11:49
NEO
--%
Neogenomics's MACD and KDJ Indicators Signal Bearish Trend on 15-Minute Chart.
Wednesday Oct 29, 2025
16:48
NEO
--%
Neogenomics's MACD and KDJ Indicators Signal Bearish Trend on 15-Minute Chart.
Tuesday Oct 28, 2025
16:15
NEO
--%
NeoGenomics Achieves Record Clinical Revenue, Pursues $30B MRD Market and Reiterates 2025 Growth Targets
13:30
NEO
--%
NeoGenomics Q3 Results: Revenue Up 11.9%, EPS Beats Expectations.
12:05
NEO
--%
Neogenomics Triggers MACD and KDJ Death Crosses on 15-Minute Chart
08:59
NEO
--%
NeoGenomics Q3 Sales Beat Estimates, Stock Surges
08:19
NEO
--%
NeoGenomics Q3 Earnings Top Estimates on Clinical Revenue Growth
08:14
NEO
--%
NeoGenomics Q3 revenue up 12% YoY to $188mln, reaffirms FY23 guidance.
Monday Oct 27, 2025
16:33
NEO
--%
NeoGenomics Advances Personalized Cancer Diagnostics Through RaDaR ST Molecular Residual Disease Test